Anilocus provides comprehensive safety pharmacology studies evaluating cardiovascular, respiratory, and central nervous system effects of drug candidates. Our capabilities include specialized behavioral assessments, physiological monitoring, and tissue analysis to identify potential safety liabilities and support regulatory submissions for safe drug development programs.
Anilocus provides pharmacodynamics studies to assess drug effects on biological systems, measuring therapeutic responses, dose-response relationships, and mechanism of action in preclinical research applications.
Anilocus provides comprehensive pharmacokinetics studies including ADME analysis, bioanalytical method development, and tissue distribution assessment. Our capabilities include LC-MS analysis, qPCR quantification, and ex vivo biodistribution tracking to support drug development from lead optimization through IND-enabling studies with regulatory-compliant data generation.
Anilocus provides behavioral neuroscience capabilities including custom apparatus design, integrated detection systems, and post-behavioral molecular analysis for rodent behavioral research applications.
Anilocus provides imaging services including fluorescence and confocal microscopy, ImageStream cytometry, and live-cell analysis for ex vivo tissue characterization and morphological phenotyping applications.
Anilocus provides analytical services including nanoparticle characterization, drug formulation analysis, biomaterial-tissue interaction studies, and ex vivo biodistribution tracking for preclinical research applications.
Anilocus provides cellular and molecular biology services including primary cell isolation, ex vivo stimulation, immune profiling, transfection, and fluorescence microscopy for preclinical research applications.
Anilocus provides bioanalytical services including qPCR, Western blot, flow cytometry, metabolic profiling, and histological evaluation using specialized equipment for preclinical research applications.
Anilocus offers in vivo preclinical services including rodent study design, surgical procedures, behavioral studies, and tissue processing with full IACUC compliance at our Germantown, MD facility.
Anilocus provides preclinical services for gene therapy research including in vivo delivery studies, biodistribution analysis, immune profiling, and behavioral assessments. Our capabilities span from initial formulation characterization through tissue analysis, supporting gene therapy development from proof-of-concept to IND-enabling studies with specialized equipment and expertise.
Bold ideas and breakthrough research. Expert analysis on the innovations and drug development for the most important people in the world: patients.
Use this form to send your questions to our research team about our preclinical contract research services.
We are here to help!
